A carregar...

Coverage For High Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D

OBJECTIVE: One in four Medicare beneficiaries with rheumatoid arthritis (RA) use high cost biologic disease modifying drugs (DMARDs), and spending for these drugs has risen sharply for Medicare Part D. We conducted the first systematic, national investigation of how Part D plans cover biologic DMARD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Yazdany, Jinoos, Dudley, R. Adams, Chen, Randi, Lin, Grace A., Tseng, Chien-Wen
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4464809/
https://ncbi.nlm.nih.gov/pubmed/25900105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39079
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!